CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma
Most Cited Paper
in CRISPR and Genetic Engineering
18 Months Post-Publication
Class of 2026
“CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma”
A research intelligence initiative by Pepkio
pri.pepkio.com/top-papers/crispr-and-genetic-engineering/2026/
Topics
CD70-targeted CAR T-cell therapy · CTX130 · CAR T cells · clear cell renal cell carcinoma · clear cell renal cell carcinoma · relapsed/refractory ccRCC · RCC xenograft tumors · dose-limiting toxicity · durable complete response · CTX131 · CAR T cells · synergistic potency edits · CD70+ malignancies · phase I first-in-human clinical trial · disease control rate · CAR T cells
Share
Cite this ranking
Pepkio Research Index (PRI). Topics and Trends in Most Cited CRISPR and Genetic Engineering Papers, Class of 2026. https://pri.pepkio.com/top-papers/crispr-and-genetic-engineering/2026. Accessed 2026-07-21. Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459